25I-NB34MD

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
25I-NB34MD
25I-NB34MD.svg
Clinical data
ATC code
  • none
Legal status
Legal status
Identifiers
CAS Number
ChemSpider
Chemical and physical data
Formula C18H20INO4
Molar mass 441.259 g/mol
3D model (JSmol)

25I-NB34MD (NB34MD-2C-I) is a derivative of the phenethylamine hallucinogen 2C-I, which acts as a potent partial agonist for the human 5-HT2A receptor, and presumably has similar properties to 2C-I.[1] It has a binding affinity of 0.67nM at the human 5-HT2A receptor, making it several times weaker than its positional isomer 25I-NBMD and a similar potency to 25I-NBF.[2][3]

Legality[edit]

Hungary[edit]

Illegal.[4]

Japan[edit]

Illegal.[5]

Sweden[edit]

The Riksdag added 25I-NB34MD to Narcotic Drugs Punishments Act under swedish schedule I ("substances, plant materials and fungi which normally do not have medical use") as of June 9, 2015, published by Medical Products Agency (MPA) in regulation LVFS 2015:4 listed as 25I-NB34MD, and 2-(4-jodo-2,5-dimetoxifenyl)-N-[(3,4-metylendioxifenyl)metyl]etanamin.[6]

United Kingdom[edit]

This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.[7]


Analogues and derivatives[edit]

References[edit]